China’s Process For Allowing The Export Of COVID-19 Products Without NMPA Approval
The Chinese government announced a process to export particular devices without NMPA approval.
China
Learn more about our China work.
Medtech Industry Urges Additional Tariff Relief to Combat COVID-19
WASHINGTON, D.C. – The Advanced Medical Association (AdvaMed) requested the United States Trade Representative (USTR) provide additional tariff exclusions for medical devices, components and supplies coming from China needed in…
Non-Invasive Ventilators Offer Life-Saving Treatment for Less Severe COVID Patients
WASHINGTON – New clinical evidence produced in recent weeks has shown the benefits of non-invasive ventilators for use in less severe cases of COVID-19-related respiratory problems, which constitute the majority…
Medtech Fighting Coronavirus on Multiple Fronts
WASHINGTON, D.C. – Since the onset of the coronavirus (COVID-19) outbreak, at least 31 AdvaMed member companies have donated medical products worth approximately $26.8 million and made cash donations worth $4.1…
The Impact of Applying Price Regulation to Medical Devices in Emerging Markets
The objective of this study is to assess the potential impact of pricing regulation of medical devices in Brazil, China, Colombia and India.
Memo on Medical Technology Artificial Intelligence (AI) in China
Accelerating the advancement of AI could help China tackle some of its most difficult healthcare challenges.
AdvaMed China Brochure (English)
Many AdvaMed members have made substantial investments in China, including establishment of research and manufacturing facilities and other efforts that contribute to China’s growth.